The results suggested that high SLC11A1 expression was associated with poor outcomes in ACC, KIRC, LGG, GBM, LIHC, LAML, PRAD, PAAD, and THYM. The gene discussed is SLC11A1; the disease is adrenal cortex carcinoma.